{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:44:56Z","timestamp":1795106696075,"version":"4.10.3"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanepe.2026.101768","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:01:43Z","timestamp":1783587703000},"page":"101768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2495-790X","authenticated-orcid":false,"given":"Katharina A.","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-9132","authenticated-orcid":false,"given":"Matthias","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva V.","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1371-1947","authenticated-orcid":false,"given":"Philip F.","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Haindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-7441","authenticated-orcid":false,"given":"Martina","family":"Schatzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9227-8017","authenticated-orcid":false,"given":"Aylin","family":"Akifova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela M.","family":"Allmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Kozakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"G\u00f6rzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3993-6538","authenticated-orcid":false,"given":"Hannes","family":"Vietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Flesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uptal D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Halleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-5942","authenticated-orcid":false,"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-912X","authenticated-orcid":false,"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lanepe.2026.101768_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1681\/ASN.2020081215","article-title":"Exploring the complexity of death-censored kidney allograft failure","volume":"32","author":"Mayrdorfer","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101768_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101768_bib3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/13696998.2021.1964267","article-title":"Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US","volume":"24","author":"Hart","year":"2021","journal-title":"J Med Econ"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101768_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0000000000003095","article-title":"Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantion society working group","volume":"104","author":"Schinstock","year":"2020","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101768_bib5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/ndt\/gfaf097","article-title":"Antibody-mediated rejection-treatment standard","volume":"40","author":"B\u00f6hmig","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lanepe.2026.101768_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14343","article-title":"Targeting CD38 in antibody-mediated rejection","volume":"38","author":"Mayer","year":"2025","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101768_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/TP.0000000000003247","article-title":"CD38 antibody daratumumab for the treatment of chronic active antibody-mediated kidney allograft rejection","volume":"105","author":"Doberer","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.lanepe.2026.101768_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.13213","article-title":"Donor-derived cell-free DNA as a companion biomarker for AMR treatment with daratumumab: case series","volume":"37","author":"Osmanodja","year":"2024","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101768_bib9","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.ekir.2025.07.009","article-title":"Anti-CD38 daratumumab treatment of chronic active antibody-mediated kidney allograft rejection","volume":"10","author":"Lye","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101768_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101768_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.kint.2024.09.023","article-title":"Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients","volume":"107","author":"Budde","year":"2025","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101768_bib12","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101768_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2021091191","article-title":"The trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies","volume":"33","author":"Halloran","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101768_bib14","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101768_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101768_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65153-9","article-title":"Continuous indices to assess the phenotypic spectrum of kidney transplant rejection","volume":"16","author":"Vaulet","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101768_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000004624","article-title":"The molecular phenotype of kidney transplants: insights from the MMDx project","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.lanepe.2026.101768_bib18","article-title":"Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study","volume":"366","author":"Loupy","year":"2019","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101768_bib19","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/TP.0000000000004212","article-title":"Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation","volume":"106","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101768_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001794","article-title":"Association of blood donor-derived cell-free DNA levels with Banff scores and histopathological lesions in kidney allograft biopsies: results from an observational study","volume":"11","author":"Akifova","year":"2025","journal-title":"Transplant Direct"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101768_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A randomized trial of bortezomib in late antibody-mediated rejection (BORTEJECT)","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101768_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial","volume":"18","author":"Moreso","year":"2018","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101768_bib23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/TP.0000000000003274","article-title":"Change in estimated GFR and risk of allograft failure in patients diagnosed with late active antibody-mediated rejection following kidney transplantation","volume":"105","author":"Irish","year":"2021","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101768_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.kint.2025.04.023","article-title":"A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients","volume":"108","author":"Mulley","year":"2025","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101768_bib25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajt.2024.12.004","article-title":"Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system","volume":"25","author":"Lombardi","year":"2025","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101768_bib26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/ajt.15810","article-title":"Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial","volume":"20","author":"Doberer","year":"2020","journal-title":"Am J Transplant"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:40:12Z","timestamp":1793220012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226001808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S2666776226001808"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101768","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101768"}}